What Surgeons Need to Know About Gene Therapy for Cancer.
Cancer
Cell therapy
Gene editing
Gene therapy
Immunotherapy
Oncolytic viruses
Journal
Advances in surgery
ISSN: 1878-0555
Titre abrégé: Adv Surg
Pays: United States
ID NLM: 0045335
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
entrez:
12
9
2022
pubmed:
13
9
2022
medline:
15
9
2022
Statut:
ppublish
Résumé
The broad field of gene therapy offers numerous innovative approaches for cancer treatment. An understanding of the different modalities including gene replacement therapy, cancer vaccines, oncolytic viruses, cellular therapy, and gene editing is essential for managing patients with neoplastic disease. As in other areas of oncology, the surgeon plays a pivotal role in the diagnosis and treatment of the disease. This review focuses on what the clinical surgeon needs to know to optimize the benefit of gene therapy for patients with cancer.
Identifiants
pubmed: 36096566
pii: S0065-3411(22)00006-9
doi: 10.1016/j.yasu.2022.02.006
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
151-168Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.